Exagen Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Exagen Diagnostics's estimated annual revenue is currently $54.7M per year.(i)
  • Exagen Diagnostics's estimated revenue per employee is $155,000

Employee Data

  • Exagen Diagnostics has 353 Employees.(i)
  • Exagen Diagnostics grew their employee count by 22% last year.

Exagen Diagnostics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Exagen Diagnostics?

Exagen Diagnostics, Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our Avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on Avise testing services, please visit www.AviseTest.com.

keywords:N/A

N/A

Total Funding

353

Number of Employees

$54.7M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Exagen Diagnostics News

2022-03-22 - Exagen Inc. Expands In-Network Benefit with Additional 22.7 ...

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: ... It is difficult to diagnose, hard to live with, a challenge to treat,...

2022-03-22 - Exagen Inc. Expands In-Network Benefit with Additional 22.7 ...

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: ... It is difficult to diagnose, hard to live with, a challenge to treat,...

2019-09-08 - PE-backed Exagen files for IPO

Exagen, an autoimmune disorders diagnostics company backed by Sun Mountain Capital and HIG Capital, has revived IPO plans previously ...

2019-09-03 - Diagnostic test maker Exagen revives IPO with latest filing to raise $58 million

Exagen, which sells diagnostic blood tests that detect lupus and rheumatoid arthritis, revived its plans to go public by filing an S-1 on Friday ...

2019-09-03 - Exagen Files Registration To Begin U.S. IPO Process

Vista, California-based Exagen was founded in 2010 to develop a family of diagnostic tools for various chronic autoimmune diseases.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$79.9M355-6%N/A
#2
$198.4M484-1%N/A
#3
$180.6M5359%N/A
#4
$97.7M539-7%N/A
#5
$169.1M596-6%N/A